EVH Company Profile and Key Details
NYSE : EVH
Evolent Health
$2.85
-0.04-1.38%
At Close 4:00 PM74.11
B+ESG ScoreESG Rating
Price Chart
Stock Price Today
Evolent Health, Inc. (EVH) stock declined over -1.38%, trading at $2.85 on NYSE, down from the previous close of $2.89. The stock opened at $2.88, fluctuating between $2.82 and $2.93 in the recent session.
Stock Snapshot
2.89
Prev. Close
330.52M
Market Cap
2.82
Day Low
-1.82
P/E Ratio
-1.57
EPS (TTM)
1
Cash Flow per Share
2.88
Open
115.97M
Number of Shares
2.93
Day High
98.51%
Free Float in %
9.4
Book Value
2.58M
Volume
Relevant Articles
SEC Fillings
Current Report (8-k)
| Filing Date | Accepted Date | |
|---|---|---|
Annual Report (10-k)
| Filing Date | Accepted Date | |
|---|---|---|
Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Feb 06, 2026 | 2.88 | 2.94 | 2.82 | 2.85 | 2.86M |
| Feb 05, 2026 | 3.04 | 3.13 | 2.89 | 2.89 | 4.21M |
| Feb 04, 2026 | 3.09 | 3.18 | 3.01 | 3.06 | 2.49M |
| Feb 03, 2026 | 3.25 | 3.33 | 3.04 | 3.09 | 2.27M |
| Feb 02, 2026 | 3.18 | 3.43 | 3.14 | 3.26 | 4.75M |
| Jan 30, 2026 | 3.18 | 3.28 | 3.16 | 3.21 | 2.51M |
| Jan 29, 2026 | 3.22 | 3.33 | 3.17 | 3.24 | 2.64M |
| Jan 28, 2026 | 3.40 | 3.48 | 3.22 | 3.23 | 2.69M |
| Jan 27, 2026 | 3.67 | 3.67 | 3.32 | 3.40 | 4.48M |
| Jan 26, 2026 | 3.92 | 3.98 | 3.69 | 3.71 | 1.91M |
| Jan 23, 2026 | 3.82 | 4.06 | 3.80 | 3.94 | 3.16M |
| Jan 22, 2026 | 3.80 | 3.91 | 3.78 | 3.84 | 1.91M |
| Jan 21, 2026 | 3.94 | 3.97 | 3.74 | 3.80 | 2.55M |
| Jan 20, 2026 | 3.70 | 3.99 | 3.68 | 3.94 | 3.82M |
| Jan 16, 2026 | 3.93 | 3.97 | 3.71 | 3.77 | 6.98M |
| Jan 15, 2026 | 3.90 | 3.97 | 3.82 | 3.94 | 1.9M |
| Jan 14, 2026 | 4.01 | 4.06 | 3.89 | 3.90 | 2.3M |
| Jan 13, 2026 | 4.15 | 4.19 | 4.01 | 4.01 | 3.96M |
| Jan 12, 2026 | 4.14 | 4.20 | 3.96 | 4.15 | 3.45M |
| Jan 09, 2026 | 4.17 | 4.25 | 4.08 | 4.17 | 1.97M |
Contact Details
About Company
Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients, population health performance that delivers patient-centric cost-effective care. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics in oncology and cardiology; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington, Virginia.
Company Information
| Employees | 4500 |
| Beta | 0.25 |
| Sales or Revenue | $1.96B |
| 5Y Sales Change% | 1.177% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Healthcare Information Services |
Stock Peers
VEEV
-0.2-0.11%
Veeva Systems Inc.$183.65HNGE-0.62-1.95%
Hinge Health, Inc.$31.17DOCS-5.59-16.78%
Doximity, Inc.$27.73CTEV0.21+0.82%
Claritev Corporation$25.91MPLN-0.36-1.53%
MultiPlan Corporation$23.15PHR-0.39-3.10%
Phreesia, Inc.$12.20AGTI-0.05-0.50%
Agiliti, Inc.$10.05TDOC0.275+5.81%
Teladoc Health, Inc.$5.01AMWL0.19+4.47%
American Well Corporation$4.44UPH0.0251+9.13%
UpHealth, Inc.$0.30Company Overview
Evolent Health, Inc. (NYSE:EVH) closed at $2.85 USD, losing -$0.04 (-1.38%) from the previous close of $2.89. The stock is currently within 5% of its 52-week low $2.82 and $12.06. With a market capitalization of about $330.52 million, Evolent Health, Inc. is classified as a small-cap and shows lower-than-market volatility (beta ~0.24). Key stats such as the average daily volume over the past year has been around 3.89 million shares, volume is running light vs its 52-week average. Headquartered in Arlington, VA, Evolent Health, Inc. operates in the Healthcare sector and the Medical - Healthcare Information Services industry. Led by CEO Seth Barrie Blackley, the company employs approximately 4,500 people and listed since June 05, 2015. Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States.
Technical Performance
Short-term trend indicators are bullishly aligned (SMA20 -20.17%, SMA50 -26.0%, SMA200 -61.87%). The stock’s 14-day RSI is 22.21 (weak momentum), while the ATR of 0.22 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -76.38% below its high and over -1.38% above its low. Average 10-day trading volume of 3.21 million shares is below the 3-month average of 3.78 million, indicating normal recent market interest.
Dividend & Fair Value
Evolent Health, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$11.19. This means the shares are trading below this model’s fair value.
Earnings & Analyst Outlook
Evolent Health, Inc. generated EPS of -$1.57 over the past year. Five-year average earnings growth is 25.98%. Wall Street analysts project EPS growth of 8.33% annually over the next five years. The latest quarter delivered EPS of $0.05. The next quarter is forecast at $0.05. Next year's EPS is expected at $39.72. Analyst sentiment is bullish. Analyst rating data shows there are 11 Strong Buy ratings, 13 Buy ratings, 1 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $20.00 to $7.00. The high target offers 601.75% upside. The low target suggests 145.61% downside. The mean target is $12.88. This offers 351.93% upside. Evolent Health, Inc. earnings surprise history is frequent misses against expectations. The quarter that ended November 06, 2025, missed forecasts by -50.0%. The prior quarter beat by -211.11%. Over the last six quarters, Apple has recorded several small beats. These include 42.86% in August 08, 2024.
Shareholding & Insider Activity
Evolent Health, Inc. has 115.97 million shares outstanding. The public float is 91.32 million shares, elevated short interest at 16.44% of float. This equals 18.83 million shares. The short ratio is 7.11 days. Institutional investors hold 110.41% of the float. Insiders own 1.54%. WILLIAMS FRANK J holds 819.81 thousand shares, Blackley Seth has 762.22 thousand shares and McCarthy Daniel Joseph has 389.00 thousand shares. Over the past six months, insider transactions show net buying. They sold 0.00 shares across 0 transactions.
Frequently Asked Questions
What is the current Evolent Health, Inc. (EVH) stock price?
Evolent Health, Inc. (NYSE: EVH) stock price is $2.85 in the last trading session. During the trading session, EVH stock reached the peak price of $2.93 while $2.82 was the lowest point it dropped to. The percentage change in EVH stock occurred in the recent session was -1.38% while the dollar amount for the price change in EVH stock was - $0.04.
EVH's industry and sector of operation?
The NYSE listed EVH is part of Medical - Healthcare Information Services industry that operates in the broader Healthcare sector. Evolent Health, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of EVH?
Mr. Dan McCarthy
Chief Information Officer
Ms. Kali Beyah
Chief People & Brand Officer
Mr. Seth R. Frank
Vice President of Investor Relations
Mr. Jonathan David Weinberg J.D.
Chief Legal Officer, Gen. Counsel & Sec.
Ms. Emily Rafferty
Chief Operating Officer
Mr. John Paul Johnson
Chief Financial Officer
Mr. Frank John Williams
Co-Founder & Chairman
Ms. Jessica Somers
Senior Vice President of Corporation Devel.
Mr. Aammaad Shams
Chief Accounting Officer
Mr. Seth Barrie Blackley
Co-Founder, Chief Executive Officer & Director
Mr. Steve Tutewohl FSA, MAAA
Chief Operating Officer
Dr. John Tam M.D.
Chief Strategy Officer
Chief Information Officer
Ms. Kali Beyah
Chief People & Brand Officer
Mr. Seth R. Frank
Vice President of Investor Relations
Mr. Jonathan David Weinberg J.D.
Chief Legal Officer, Gen. Counsel & Sec.
Ms. Emily Rafferty
Chief Operating Officer
Mr. John Paul Johnson
Chief Financial Officer
Mr. Frank John Williams
Co-Founder & Chairman
Ms. Jessica Somers
Senior Vice President of Corporation Devel.
Mr. Aammaad Shams
Chief Accounting Officer
Mr. Seth Barrie Blackley
Co-Founder, Chief Executive Officer & Director
Mr. Steve Tutewohl FSA, MAAA
Chief Operating Officer
Dr. John Tam M.D.
Chief Strategy Officer
How EVH did perform over past 52-week?
EVH's closing price is 1.06% higher than its 52-week low of $2.82 where as its distance from 52-week high of $12.07 is -76.38%.
How many employees does EVH have?
Number of EVH employees currently stands at 4,500.
Link for EVH official website?
Official Website of EVH is: https://www.evolenthealth.com
How do I contact EVH?
EVH could be contacted at phone 571 389 6000 and can also be accessed through its website. EVH operates from 800 North Glebe Road, Arlington, VA 22203, United States.
How many shares of EVH are traded daily?
EVH stock volume for the day was 2.58M shares. The average number of EVH shares traded daily for last 3 months was 3.89M.
What is the market cap of EVH currently?
The market value of EVH currently stands at $330.52M with its latest stock price at $2.85 and 115.97M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep